Administer Xolair 75 to 375 mg by subcutaneous injection every 2 or 4 weeks. Determine dose (mg) and dosing frequency by serum total IgE level (IU/mL) measured before the start of treatment,...
XOLAIR is indicated for add-on maintenance treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) in adult patients 18 years of age and older with inadequate response to nasal corticosteroids.
label - Food and Drug Administration
Initiate XOLAIR therapy in a healthcare setting, closely observe patients for an appropriate period of time after XOLAIR administration and be prepared to manage anaphylaxis which can be...
XOLAIR® (omalizumab)
Learn about XOLAIR®, a self-administered treatment for allergic asthma, chronic rhinosinusitis with nasal polyps, chronic spontaneous urticaria, and food allergy. See full prescribing, safety, & Boxed Warning info.
XOLAIR is indicated for patients 6 years of age and older with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose...
XOLAIR prefilled syringe should be injected by a caregiver. See the detailed Instructions for Use that comes with XOLAIR for information on the right way to prepare and inject XOLAIR. XOLAIR is given in 1 or more injections under the skin (subcutaneous), 1 time every 2 or 4 weeks.
Health care providers administering XOLAIR should be prepared to manage anaphylaxis that can be life-threatening. Inform patients of the signs and symptoms of anaphylaxis and instruct them to seek immediate medical care should symptoms occur.
XOLAIR® has been shown to significantly decrease the incidence of asthma exacerbations and improve control of asthma symptoms in these patients. the treatment of adults and adolescents (12 years of age and above) with chronic idiopathic urticaria (CIU) who remain symptomatic despite H1 antihistamine treatment.
Xolair® (omalizumab) | Novartis United States of America
Xolair® (omalizumab) Product Information. Active ingredients - for injection. for subcutaneous use. Information Resources. Downloadable Content . Resources. Prescribing information (PDF 3.27 MB) Medication Guide (PDF 187.92 KB) Instructions for Use ...
• Use XOLAIR exactly as prescribed by your healthcare provider • Keep the prefilled syringe or autoinjector out of the reach of children • Read the full Medication Guide and Instructions for Use within the package insert that comes with XOLAIR for information on how to properly prepare, inject, store, and dispose of prefilled syringes
- 某些结果已被删除